- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT02398812
The Interprofessional Medication Assessment for Older Patients
The Interprofessional Medication Assessment for Older Patients - a Multicenter Randomized Trial in Primary Care Setting
연구 개요
상세 설명
Aging increases the risk of adverse effects and interactions caused by medication. Medication reconciliation and medication review are well-known practices to optimize medicines use. Both interventions usually require a team-based approach to be effective. Medication reconciliation is the process of obtaining and documenting a complete and accurate list of current patient medications and comparing this list with medication orders at each point of care transition to identify and rectify any discrepancies before patient harm occurs. Medication review is the process of evaluating current medication treatment to manage the risk and optimize the outcomes of medication treatment by detecting, solving, and preventing medication-related problems. The present study focuses on medication assessment including both medication reconciliation and review combined to clinical assessment of an individual patient.
According to a systematic review there is a need for research focusing on medication management in community settings and especially to assess the impact of medication assessment on clinical outcomes.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Forssa, 핀란드, FI 30100
- Welfare district of Forssa
-
Haapajärvi, 핀란드, FI 85800
- Selänne Basic Health Care District
-
Juva, 핀란드, FI-51900
- Juva Health Care
-
Lahti, 핀란드, FI-15100
- City of Lahti, home care
-
Savonlinna, 핀란드, FI-57100
- Eastern Savo Hospital District
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
Home dwelling ≥65 years-old persons registered to public home care services and who
- have had dizziness, orthostatic hypotension or have fallen or
- use at least six medicines
Exclusion Criteria:
Home care is not responsible for patient's medication, for example due to severe chronic illness (for example severe renal insufficiency or cancer with active treatment in secondary or tertiary care).
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
활성 비교기: Active comparator
In addition to usual care, participants allocated to intervention group will receive medication assessment and treatment plan based on it
|
Intervention
|
|
간섭 없음: Usual care
Usual care (reference group).
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
기간 |
|---|---|
|
Functional capacity IADL (Instrumental Activities of Daily Living)
기간: at 6 months from baseline
|
at 6 months from baseline
|
|
Functional capacity ADL (Activities of daily living;KATZ)
기간: at 6 months from baseline
|
at 6 months from baseline
|
|
Functional capacity TUG (Timed up and go)
기간: at 6 months from baseline
|
at 6 months from baseline
|
|
Functional capacity MMSE ( Mini-mental state examination)
기간: at 6 months from baseline
|
at 6 months from baseline
|
|
Functional capacity GDS (Geriatric Depression Scale)-15
기간: at 6 months from baseline
|
at 6 months from baseline
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Use of health care services
기간: at 6 and 12 months from baseline
|
visits to physician, hospital days and nursing care at home
|
at 6 and 12 months from baseline
|
|
Need of services delivered to home
기간: at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
|
|
Number of medicines
기간: at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
|
|
Quality of medicines
기간: at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
|
|
Cost of medicines
기간: at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
|
|
Health related quality of life assessed with EQ-5D
기간: at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
공동 작업자 및 조사자
수사관
- 연구 의자: Pekka Mäntyselkä, MD, Professor
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- ILMA
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .